Insiders · Profile

MOLINA ARTURO MD

Chief Medical Officer at Protagonist Therapeutics · Chief Medical Officer at SUTRO BIOPHARMA. Filing since 14 May 2020. CIK 0001398940

PTGX Protagonist Therapeutics, Inc Chief Medical Officer · 14 trades STRO SUTRO BIOPHARMA, INC. Chief Medical Officer · 1 trade

Company

Date

Role

Action

Shares

Amount

Of holding

PTGX Protagonist Therapeutics, Inc

26 Mar 2026

Chief Medical Officer

Sold at will

15,000

$1.57M

15.1%

PTGX Protagonist Therapeutics, Inc

27 Jan 2026

Chief Medical Officer

Sold at will

5,000

$410.00K

5.6%

PTGX Protagonist Therapeutics, Inc

26 Jan 2026

Chief Medical Officer

Sold at will

5,000

$411.40K

5.6%

PTGX Protagonist Therapeutics, Inc

23 Jan 2026

Chief Medical Officer

Sold at will

13,151

$1.08M

13.5%

PTGX Protagonist Therapeutics, Inc

20 Jan 2026

Chief Medical Officer

Sold at will

9,514

$784.71K

8.9%

PTGX Protagonist Therapeutics, Inc

17 Nov 2025

Chief Medical Officer

Sold at will

2,712

$229.90K

3.2%

PTGX Protagonist Therapeutics, Inc

10 Jun 2025

Chief Medical Officer

Sold at will

10,000

$570.30K

10.7%

PTGX Protagonist Therapeutics, Inc

9 Jun 2025

Chief Medical Officer

Sold at will

10,000

$555.10K

10.7%

PTGX Protagonist Therapeutics, Inc

13 Mar 2025

Chief Medical Officer

Sold at will

30,514

$1.70M

26.7%

PTGX Protagonist Therapeutics, Inc

16 Jan 2025

Chief Medical Officer

Sold at will

3,640

$0.00

4.2%

PTGX Protagonist Therapeutics, Inc

27 Nov 2024

Chief Medical Officer

Sold at will

26,000

$1.16M

35.9%

PTGX Protagonist Therapeutics, Inc

26 Nov 2024

Chief Medical Officer

Sold at will

5,529

$252.12K

10.6%

PTGX Protagonist Therapeutics, Inc

15 Nov 2024

Chief Medical Officer

Sold at will

1,906

$78.11K

3.9%

PTGX Protagonist Therapeutics, Inc

15 Nov 2023

Chief Medical Officer

Sold at will

1,848

$30.01K

7.6%

STRO SUTRO BIOPHARMA, INC.

14 May 2020

Chief Medical Officer

Bought

6,451

$50.00K

115%

15 decisions on file.